| Ytd | -61.66% | |
| 1y | -73.77% |
| Open | 0.48 | Prev Close | 0.48 | Low | 0.47 | High | 0.50 | Mkt Cap | 75.37M |
| Vol | 768.79K | Avg Vol | 3.45M | EPS | -0.13 | P/E | -3.67 | Forward P/E | 178.00 |
| Beta | 1.65 | Short Ratio | 14.20 | Inst. Own | 81.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 0.58 | 200-d Avg | 1.02 | 1yr Est | 6.00 |
HRTX News
BV, RAIL and HRTX have been added to the Zacks Rank #5 (Strong Sell) List on July 15th, 2026.
Top Wall Street analysts changed outlook on top names. For all rating changes, upgrades and downgrad
CARY, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or th
Heron Therapeutics, Inc. (HRTX) Q1 2026 Earnings Call Transcript
Heron Therapeutics NASDAQ: HRTX said first-quarter 2026 results were pressured by seasonal factors a
The headline numbers for Heron Therapeutics (HRTX) give insight into how the company performed in th
Heron Therapeutics (HRTX) came out with a quarterly loss of $0.04 per share versus the Zacks Consens
CARY, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a lik
CARY, N.C., April 27, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or t
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript
While the top- and bottom-line numbers for Heron Therapeutics (HRTX) give a sense of how the busines
– ZYNRELEF ® and APONVIE ® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise – Ach
HRTX has reported preliminary Q4'25 net revenues, with Zynrelef experiencing a breakout quarter. Apo
CARY, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or th
New York State Common Retirement Fund raised its stake in Heron Therapeutics, Inc. (NASDAQ: HRTX) by
Heron Therapeutics (NASDAQ: HRTX - Get Free Report) and Enliven Therapeutics (NASDAQ: ELVN - Get Fre
CARY, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or th
Heron Therapeutics, Inc. (NASDAQ: HRTX - Get Free Report) has been assigned a consensus rating of "H
Congress Park Capital LLC lifted its holdings in shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) b
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it
On Tuesday, 647 companies set new 52-week lows.
During Thursday's session, 406 companies made new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q
During Monday's trading, 1214 companies set new 52-week lows.
Monday's session saw 84 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday